Scott M. Gilbert

Also affiliated with Moffitt Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “PD60-12 DISCRETIONARY AND NECESSARY READMISSION AFTER RADICAL CYSTECTOMY”.

PD60-12 DISCRETIONARY AND NECESSARY READMISSION AFTER RADICAL CYSTECTOMY

The Journal of Urology(2020)10.1097/ju.0000000000000977.012

N/A

0DataRank · unranked

0 citations

Salim Cheriyan, Richard R. Reich, Ali Hajiran, Logan Zemp, Michael Poch +7 more

Preliminary results from phase Ib/II neoadjuvant CG0070 and nivolumab (N) for cisplatin (C)-ineligible muscle invasive bladder cancer (MIBC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4574

N/A

0DataRank · unranked

3 citations

Philippe E. Spiess, Wade J. Sexton, Scott M. Gilbert, Michael Poch, Julio M. Pow‐Sang +11 more